Skip to main content
SpringerLink
Log in

Splenectomy in ITP: we keep removing a healthy functional organ

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lozano ML, Revilla N, Gonzalez-Lopez TJ, Novelli S, González-Porras JR, Sánchez-Gonzalez B, Bermejo N, Pérez S, Lucas FJ, Álvarez MT, Arilla MJ, Perera M, do Nascimento J, Campos RM, Casado LF, Vicente V (2016) Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines. Ann Hematol 95:1089–1098. doi:10.1007/s00277-016-2665-3

    Article  PubMed  Google Scholar 

  2. Rodeghiero F, Ruggeri M (2014) ITP and international guidelines: what do we know, what do we need? Presse Med 43:e61–67. doi:10.1016/j.lpm.2014.02.004

    Article  PubMed  Google Scholar 

  3. Deuson R, Danese M, Mathias SD, Schoonen M, Fryzek J (2012) The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim. J Med Econ 15:956–976. doi:10.3111/13696998.2012.688902

    Article  PubMed  Google Scholar 

  4. Theilacker C, Ludewig K, Serr A, Schimpf J, Held J, Bögelein M, Bahr V, Rusch S, Pohl A, Kogelmann K, Frieseke S, Bogdanski R, Brunkhorst FM, Kern WV (2016) Splenectomy, pneumococcus, and fulminant infection (SPLEEN OFF) study group. overwhelming postsplenectomy infection: a prospective multicenter cohort study. Clin Infect Dis 62:871–878. doi:10.1093/cid/civ1195

    Article  PubMed  Google Scholar 

  5. Kristinsson SY, Gridley G, Hoover RN, Check D, Landgren O (2014) Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up. Haematologica 99:392–398. doi:10.3324/haematol.2013.092460

    Article  PubMed  PubMed Central  Google Scholar 

  6. Moulis G, Lapeyre-Mestre M, Mahévas M, Montastruc JL, Sailler L (2015) Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France. Am J Hematol 90:301–305. doi:10.1002/ajh.23930

    Article  CAS  PubMed  Google Scholar 

  7. Gonzalez-Porras JR, Escalante F, Pardal E, Sierra M, Garcia-Frade LJ, Redondo S, Arefi M, Aguilar C, Ortega F, de Cabo E, Fisac RM, Sanz O, Esteban C, Alberca I, Sanchez-Barba M, Santos MT, Fernandez A, Gonzalez-Lopez TJ (2013) Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia. Eur J Haematol 91:236–341. doi:10.1111/ejh.12146

    Article  PubMed  Google Scholar 

  8. Chugh S, Darvish-Kazem S, Lim W, Crowther MA, Ghanima W, Wang G, Heddle NM, Kelton JG, Arnold DM (2015) Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis. Lancet Haematol 2:e75–81. doi:10.1016/S2352-3026(15)00003-4

    Article  PubMed  Google Scholar 

  9. Michel M, Wasser J, Godeau B, Aledort L, Cooper N, Tomiyama Y, Khellaf M, Wang X (2015) Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia. Ann Hematol 94:1973–1980. doi:10.1007/s00277-015-2485-x

    Article  CAS  PubMed  Google Scholar 

  10. Grainger JD, Locatelli F, Chotsampancharoen T, Donyush E, Pongtanakul B, Komvilaisak P, Sosothikul D, Drelichman G, Sirachainan N, Holzhauer S, Lebedev V, Lemons R, Pospisilova D, Ramenghi U, Bussel JB, Bakshi KK, Iyengar M, Chan GW, Chagin KD, Theodore D, Marcello LM, Bailey CK (2015) Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet 386:1649–58. doi:10.1016/S0140-6736(15)61107-2

    Article  CAS  PubMed  Google Scholar 

  11. González-López TJ, Pascual C, Álvarez-Román MT, Fernández-Fuertes F, Sánchez-González B, Caparrós I, Jarque I, Mingot-Castellano ME, Hernández-Rivas JA, Martín-Salces M, Solán L, Beneit P, Jiménez R, Bernat S, Andrade MM, Cortés M, Cortti MJ, Pérez-Crespo S, Gómez-Núñez M, Olivera PE, Pérez-Rus G, Martínez-Robles V, Alonso R, Fernández-Rodríguez A, Arratibel MC, Perera M, Fernández-Miñano C, Fuertes-Palacio MA, Vázquez-Paganini JA, Gutierrez-Jomarrón I, Valcarce I, de Cabo E, Sainz A, Fisac R, Aguilar C, Paz Martínez-Badas M, Peñarrubia MJ, Calbacho M, de Cos C, González-Silva M, Coria E, Alonso A, Casaus A, Luaña A, Galán P, Fernández-Canal C, Garcia-Frade J, González-Porras JR (2015) Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia. Am J Hematol 90:E40–3. doi:10.1002/ajh.23900

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematology Department, IdISSC, Hospital Clínico San Carlos, 28040, Madrid, Spain

    Eduardo Anguita

  2. Department of Clinical Microbiology and Infectious Diseases, Hospital Clínico San Carlos, 28040, Madrid, Spain

    Francisco Javier Candel

  3. Emergency Department, IdISSC, Hospital Clínico San Carlos, 28040, Madrid, Spain

    Juan González-Del Castillo & F. Javier Martín-Sánchez

Authors
  1. Eduardo Anguita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francisco Javier Candel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juan González-Del Castillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Javier Martín-Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduardo Anguita.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anguita, E., Candel, F.J., González-Del Castillo, J. et al. Splenectomy in ITP: we keep removing a healthy functional organ. Ann Hematol 95, 1911–1912 (2016). https://doi.org/10.1007/s00277-016-2778-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-016-2778-8

Keywords

Search

Navigation